Voretigene Neparvovec

Midwest CEPAC
January 25, 2018 10am-4pm CT

Courtyard Marriott at Briarcliff
4000 North Mulberry Drive
Kansas City, MO

The Midwest CEPAC convened to deliberate on ICER's report on voretigene neparvovec (LuxturnaTM, Spark Therapeutics).